VOYA Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-16,493
| Closed | -$548K | – | 2968 |
|
|
2022
Q4 | $548K | Sell |
16,493
-4,947
| -23% | -$159K | ﹤0.01% | 1987 |
|
|
2022
Q3 | $676K | Sell |
21,440
-264
| -1% | -$8.55K | ﹤0.01% | 1839 |
|
|
2022
Q2 | $660K | Sell |
21,704
-288
| -1% | -$7.79K | ﹤0.01% | 1666 |
|
|
2022
Q1 | $571K | Buy |
21,992
+5,211
| +31% | +$124K | ﹤0.01% | 1831 |
|
|
2021
Q4 | $342K | Sell |
16,781
-21,413
| -56% | -$411K | ﹤0.01% | 2230 |
|
|
2021
Q3 | $735K | Buy |
38,194
+74
| +0.2% | +$1.48K | ﹤0.01% | 1795 |
|
|
2021
Q2 | $846K | Sell |
38,120
-1,776
| -4% | -$37.7K | ﹤0.01% | 1751 |
|
|
2021
Q1 | $1.05M | Buy |
39,896
+3,144
| +9% | +$74.8K | ﹤0.01% | 1561 |
|
|
2020
Q4 | $687K | Buy |
36,752
+4,010
| +12% | +$74.9K | ﹤0.01% | 1724 |
|
|
2020
Q3 | $556K | Sell |
32,742
-371
| -1% | -$7.21K | ﹤0.01% | 1609 |
|
|
2020
Q2 | $771K | Sell |
33,113
-24,769
| -43% | -$359K | ﹤0.01% | 1400 |
|
|
2020
Q1 | $486K | Sell |
57,882
-938
| -2% | -$7.9K | ﹤0.01% | 1643 |
|
|
2019
Q4 | $575K | Buy |
58,820
+16,167
| +38% | +$152K | ﹤0.01% | 1813 |
|
|
2019
Q3 | $405K | Sell |
42,653
-204
| -0.5% | -$2.15K | ﹤0.01% | 1884 |
|
|
2019
Q2 | $509K | Buy |
42,857
+25,265
| +144% | +$304K | ﹤0.01% | 1765 |
|
|
2019
Q1 | $310K | Sell |
17,592
-1,634
| -8% | -$27.2K | ﹤0.01% | 2040 |
|
|
2018
Q4 | $334K | Buy |
19,226
+752
| +4% | +$12.8K | ﹤0.01% | 1956 |
|
|
2018
Q3 | $275K | Hold |
18,474
| – | – | ﹤0.01% | 2186 |
|
|
2018
Q2 | $294K | Sell |
18,474
-1,561
| -8% | -$23.3K | ﹤0.01% | 2148 |
|
|
2018
Q1 | $284K | Sell |
20,035
-2,151
| -10% | -$31.8K | ﹤0.01% | 2136 |
|
|
2017
Q4 | $311K | Hold |
22,186
| – | – | ﹤0.01% | 2118 |
|
|
2017
Q3 | $317K | Hold |
22,186
| – | – | ﹤0.01% | 2138 |
|
|
2017
Q2 | $349K | Buy |
22,186
+2,156
| +11% | +$31.1K | ﹤0.01% | 2062 |
|
|
2017
Q1 | $276K | Hold |
20,030
| – | – | ﹤0.01% | 2102 |
|
|
2016
Q4 | $355K | Sell |
20,030
-1,347
| -6% | -$23.7K | ﹤0.01% | 1954 |
|
|
2016
Q3 | $412 | Hold |
21,377
| – | – | ﹤0.01% | 1843 |
|
|
2016
Q2 | $417K | Hold |
21,377
| – | – | ﹤0.01% | 1821 |
|
|
2016
Q1 | $441K | Hold |
21,377
| – | – | ﹤0.01% | 1766 |
|
|
2015
Q4 | $439K | Hold |
21,377
| – | – | ﹤0.01% | 1807 |
|
|
2015
Q3 | $366K | Sell |
21,377
-5,072
| -19% | -$92.7K | ﹤0.01% | 1920 |
|
|
2015
Q2 | $493K | Sell |
26,449
-2,141
| -7% | -$39.7K | ﹤0.01% | 1949 |
|
|
2015
Q1 | $545K | Hold |
28,590
| – | – | ﹤0.01% | 1864 |
|
|
2014
Q4 | $471K | Sell |
28,590
-6,806
| -19% | -$117K | ﹤0.01% | 1968 |
|
|
2014
Q3 | $626K | Hold |
35,396
| – | – | ﹤0.01% | 1746 |
|
|
2014
Q2 | $731K | Hold |
35,396
| – | – | ﹤0.01% | 1715 |
|
|
2014
Q1 | $771K | Hold |
35,396
| – | – | ﹤0.01% | 1648 |
|
|
2013
Q4 | $939K | Buy |
35,396
+6,806
| +24% | +$167K | ﹤0.01% | 1502 |
|
|
2013
Q3 | $676K | Hold |
28,590
| – | – | ﹤0.01% | 1673 |
|
|
2013
Q2 | $615K | Buy |
+28,590
| New | +$617K | ﹤0.01% | 1682 |
|
Other funds holding VIVO
VOYA Investment Management's VIVO Position: Q1 2023 in Review
VOYA Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 16,493 shares — an estimated $548K sold.
VOYA Investment Management first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $1.05M in Q1 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- VOYA Investment Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- VOYA Investment Management sold 16,493 Meridian Bioscience Inc shares in Q1 2023, an estimated $548K.
- VOYA Investment Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
- VOYA Investment Management's Meridian Bioscience Inc position peaked at $1.05M in Q1 2021.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on VOYA Investment Management's 13F filing for Q1 2023, filed 15 May 2023.